0001415889-23-002167.txt : 20230208 0001415889-23-002167.hdr.sgml : 20230208 20230208175603 ACCESSION NUMBER: 0001415889-23-002167 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230207 FILED AS OF DATE: 20230208 DATE AS OF CHANGE: 20230208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guerin Mark Patrick CENTRAL INDEX KEY: 0001607714 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36020 FILM NUMBER: 23600306 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Onconova Therapeutics, Inc. CENTRAL INDEX KEY: 0001130598 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 BUSINESS PHONE: 267-759-3681 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC. DATE OF NAME CHANGE: 20090526 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC DATE OF NAME CHANGE: 20001226 4 1 form4-02082023_100254.xml X0306 4 2023-02-07 0001130598 Onconova Therapeutics, Inc. ONTX 0001607714 Guerin Mark Patrick C/O ONCONOVA THERAPEUTICS, INC 12 PENNS TRAIL NEWTOWN PA 18940 false true false false CFO AND COO Common Stock 2023-02-07 4 M 0 6900 A 19976 D Common Stock 2023-02-07 4 F 0 1785 1.36 D 18191 D Restricted Stock Units 2023-02-07 4 M 0 6900 0 D Common Stock 6900 13800 D Restricted stock units convert into common stock on a one-for-one basis. On February 7, 2022 the reporting person was granted 20,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary. /s/ Mark Guerin 2023-02-08